# Vivo Capital's Pharma Investments: 17 Startups in Its Portfolio (2026) > The 17 Pharma startups Vivo Capital has backed, by stage: $2.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/vivo-capital-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 8 - [Harmony Biosciences](https://millionrounds.com/company/harmony-biosciences) - [Tarsus Pharmaceuticals](https://millionrounds.com/company/tarsus-pharmaceuticals) - [Mereo Biopharma](https://millionrounds.com/company/mereo-biopharma) - [Whitehawk Therapeutics](https://millionrounds.com/company/whitehawk-therapeutics) - [Elevation Oncology](https://millionrounds.com/company/elevation-oncology) - [CAMP4 Therapeutics](https://millionrounds.com/company/camp4-therapeutics) - [Ventyx Biosciences](https://millionrounds.com/company/ventyx-biosciences) - [ALX Oncology](https://millionrounds.com/company/alx-oncology) ## Series C and later 4 - [Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma) - [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals) - [Poseida Therapeutics](https://millionrounds.com/company/poseida-therapeutics) - [35Pharma](https://millionrounds.com/company/35pharma) ## Series B 3 - [Allakos](https://millionrounds.com/company/allakos) - [Attralus](https://millionrounds.com/company/attralus) - [Immune-Onc Therapeutics](https://millionrounds.com/company/immune-onc-therapeutics) ## Series A 2 - [Compass Therapeutics](https://millionrounds.com/company/compass-therapeutics) - [Citrine Medicine](https://millionrounds.com/company/citrine-medicine) ## Segment by segment ### Stage not reported 8 startups · $669M raised - [**Harmony Biosciences**](https://millionrounds.com/company/harmony-biosciences) Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders. United States $248M - [**Tarsus Pharmaceuticals**](https://millionrounds.com/company/tarsus-pharmaceuticals) Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need. United States $125M - [**Mereo Biopharma**](https://millionrounds.com/company/mereo-biopharma) Mereo is a new UK-based speciality biopharmaceutical company. United Kingdom $92M - [**Whitehawk Therapeutics**](https://millionrounds.com/company/whitehawk-therapeutics) Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology. United States $88M - [**Elevation Oncology**](https://millionrounds.com/company/elevation-oncology) Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients. United States $50M - [**CAMP4 Therapeutics**](https://millionrounds.com/company/camp4-therapeutics) CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression. United States $30M - [**Ventyx Biosciences**](https://millionrounds.com/company/ventyx-biosciences) Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders. United States $27M - [**ALX Oncology**](https://millionrounds.com/company/alx-oncology) ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. United States $10M ### Series C and later 4 startups · $938M raised - [**Zenas BioPharma**](https://millionrounds.com/company/zenas-biopharma) Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. United States $420M - [**ORIC Pharmaceuticals**](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. United States $248M - [**Poseida Therapeutics**](https://millionrounds.com/company/poseida-therapeutics) Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics. United States $217M - [**35Pharma**](https://millionrounds.com/company/35pharma) 35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need. Canada $53M ### Series B 3 startups · $375M raised - [**Allakos**](https://millionrounds.com/company/allakos) Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases. United States $294M - [**Attralus**](https://millionrounds.com/company/attralus) Attralus is a clinical-stage biopharmaceutical company focused on developing innovative medicines and diagnostics for systemic amyloidosis. United States $56M - [**Immune-Onc Therapeutics**](https://millionrounds.com/company/immune-onc-therapeutics) Immune-Onc Therapeutics is a clinical-stage biopharmaceutical company based in Palo Alto, California. United States $25M ### Series A 2 startups · $337M raised - [**Compass Therapeutics**](https://millionrounds.com/company/compass-therapeutics) Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases. United States $257M - [**Citrine Medicine**](https://millionrounds.com/company/citrine-medicine) Citrine Medicine is a rare disease-focused pharmaceutical firm. - $80M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Vivo Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Vivo Capital's Biotech portfolio** 67 startups · $11B](https://millionrounds.com/portfolio-maps/vivo-capital-biotech-portfolio)[Portfolio map **Vivo Capital portfolio map** 98 startups · $17B](https://millionrounds.com/portfolio-maps/vivo-capital-portfolio-map)[Co-investors **Who invests with Vivo Capital** 73 co-investors](https://millionrounds.com/portfolio-maps/vivo-capital-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio) ## Raising from investors like Vivo Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)